GLP1R and hydrops fetalis: Therefore, the estimate of the ATE was 11.8% (95% CI 11.7%-12.7%), suggesting that the probability of having HF 5 years after treatment initiation was nearly 12% higher for patients receiving insulin compared to those receiving GLP-1 RAs.